Kernel
10361 Jefferson Boulevard, Culver City, CA, 90232, United States
Overview
Kernel is a neuroscience company that specializes in developing brain-recording technologies. Its custom-built, non-invasive brain interface acquires neural signals similar in quality to fMRI, MEG & ECoG, as easy to use as EEG. It was founded in 2016 and is headquartered in Los Angeles, California.
- Total investments
- 2
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 4
Sector focus
- Intelligent Systems
- Life Science
- Neuroscience
Investment portfolio
- Pretto
Participated · Equity · Jan 2022
Pretto operates an online mortgage-brokerage platform that enables users to simulate a loan in less than three minutes and browse the best rates on the market for free. The company says its mission is to make the search for a mortgage efficient, simple and fair, and plans to deploy its platform to all players of mortgage distribution. During its first four years Pretto financed €1 billion in real estate loans. The startup has advised more than 150,000 buyers over the last five years; its customers are mostly young and 80% are financing their homes. Pretto is in a hypergrowth phase with 170 employees and plans to hire roughly 160 positions this year. Company leadership describes the fundraising as an accelerator for its mission to change the mortgage market. Pretto is a Paris-based online mortgage broker that provides an instant simulator to show borrowers the best rates tailored to their credit profiles. Its tool reviews millions of combinations among banks' credit offers to identify the most suitable financing scheme for each real estate project. The startup supports homebuyers at each step—from simulation through experts' optimization to the final bank signature—with free customized counseling. Pretto has a team of 40 engineers, product designers and financial experts. The company plans to use new funding to recruit experts and to fine-tune its credit-scoring models, and it aims to triple its activity and hire 50 additional people by 2019.
- Doctolib
Participated · Equity · Mar 2019
Doctolib is a Paris-based healthcare platform that began as a booking and scheduling service and has expanded its product suite to include telemedicine, instant messaging, and back-office functionality. The company sells a €129-per-month SaaS to medical professionals and counts over 300,000 users of that service across France, Germany, and Italy. Those numbers imply monthly recurring revenues close to €40 million. Doctolib's strategy is to become embedded in daily healthcare operations, shifting from a 'nice to have' to an 'essential' service. The new capital will be used to fund a recruitment drive targeting the addition of over 3,500 employees over the next five years. The company’s recent financing and valuation also position it as France’s most valuable startup. Doctolib, founded in 2013 by Stanislas Niox-Chateau and based in Paris, provides an online platform that enables patients to book appointments and access video consultations. For practitioners it offers calendar software and services to improve operational efficiency, advertise activities, and strengthen cooperation with colleagues. Patients can find health professionals, book appointments 24/7, carry out teleconsultations, and access their online consultation history. The company records 30 million visits per month, serves 75,000 professionals and 1,400 health facilities in France and Germany, and employs 750 people across 40 cities. Doctolib raised €150M which valued the company at more than €1 billion. The company intends to use the funds to invest further in France and Germany, accelerate deployment of its teleconsultation service, further improve its products, and establish its presence in new countries. Doctolib offers an online booking platform that helps medical practitioners manage appointments, waiting rooms and patient communications. The service handles around 7 million bookings per month in France and has managed 1.5 million bookings in Germany, with about 30,000 health professionals and 12 million monthly visitors across both countries. Doctolib sells its service directly to practitioners—doctors pay €109 per month in France and €129 per month in Germany—instead of taking transaction fees or using medical data. The company has expanded into Germany with five offices (Berlin, Munich, Cologne, Düsseldorf and Hamburg) and employs roughly 380 people. Doctolib is building additional products to create a broader suite of services to improve communication between doctors and patients and among practitioners. It plans to hire 100 people in Germany, open an engineering office there, and hire another 100 in France as it pushes to grow penetration among doctors still using phone-based or outdated systems. Doctolib provides a comprehensive Software-as-a-Service booking platform that enables patients to browse doctors, see real-time availability, and book and manage appointments on any device. The company uses a subscription model that scales from individual GPs to large hospitals and supports all types of medical businesses. Doctolib said it will use the €26m Series C to consolidate its leadership position in France and Germany—where it is live in Berlin and plans launches in three new cities—and to accelerate longer-term European expansion. It also plans to further develop its tools and services and to recruit more than 150 new team members in 2017. As of the article, Doctolib gathered 17,000 doctors from all specialties, 435 healthcare establishments, six million monthly website visitors, and employed 300 people in over 35 cities. Founded in October 2013 and headquartered in Paris, the company has raised €50M in total funding. Doctolib offers booking management software used by health professionals to manage appointments and by patients to book visits. The platform is not just a directory: doctors who switch use Doctolib exclusively to manage bookings. Features include SMS and email reminders that the company says reduce no-shows from 10% to 2.5%, and the service is priced at $110 per month (€99). The startup complies with French law for hosting confidential health data. Doctolib reports 5,000 doctors using the platform daily, around 100 clinics, and about 2 million monthly unique visitors, adding roughly 600 doctors per month with plans to double that rate. The company employs 120 people and plans to grow to 500 employees within three years, with part of the team focused on on-the-ground doctor outreach. Doctolib plans to consolidate its leading position in France and expand into other European countries.